central bank digital- Top Reviews

South Korea's National Election Commission: South Korean President Yin Xiyue's remarks undermined South Korea's electoral system.Huachuang Securities: It was first rated as "recommended" by Zangge Mining, with a target price of 33.3 yuan. Huachuang Securities Research Report pointed out that Zangge Mining (000408.SZ) is an important producer of potassium lithium salt and copper in China, with a high dividend return to shareholders. The company actively arranges high-quality potash resources at home and abroad: three major projects, namely, Heibei potash mine in Dalangtan, Alkali-Shishan potash mine and the eastern part of deep brine potash mine in Xiaoliangshan-Dafengshan area, are steadily promoted in China, with a total exploration right of 1,400 square kilometers; Overseas has signed a potash exploration agreement with Laos. At present, the exploration report and potash mine reserve certificate have been obtained. It is estimated that the total amount of potassium chloride resources in Setani County and Ba 'e County is 984 million tons. It is estimated that the output of the first phase of potassium chloride project will be 1 million tons/year, and the scale of potassium chloride production is expected to double in the future. The company is an important manufacturer of potassium and lithium in China, and Julong Copper is expected to inject strong kinetic energy into the company's growth. Considering that Mamicho Mining has not been consolidated at present, it is estimated that the company will realize a net profit of 25.0/27.7/4.29 billion yuan in 24-26 years, which is -27%, +11% and +54.9% respectively. In 2025, it can be compared with the company's average valuation of 19 times, giving the company a valuation of 19 times in 2025, corresponding to the target price of 33.3 yuan, covering for the first time and giving a "recommended" rating.Since January 1, 2025, Chongqing maternity allowance has been issued to the insured female employees themselves. Recently, Chongqing Medical and Social Security Bureau issued the Notice on Adjusting the Payment Method for Maternity Insurance Benefits, and adjusted the payment method for maternity insurance benefits. From January 1, 2025, the application and method of maternity insurance benefits for the insured shall be applied by the insured himself or his client and issued to him by the medical insurance agency. In order to optimize the processing flow of maternity allowance, the service of "enjoy the maternity allowance immediately upon application" has been opened, that is, when the designated medical institutions in Chongqing settle the maternity medical expenses (delivery and termination of pregnancy), the medical insurance system automatically obtains the maternity-related information to calculate the maternity allowance, and the maternity allowance is paid to the insured after being approved by the medical insurance agency, and the insured or their clients do not need to provide relevant information to the medical insurance agency to declare the offline maternity allowance.

The 2.53 billion shares held by Greenland Group have been frozen. According to the legal litigation information of Tianyancha, recently, Guangxi Construction Engineering Group Co., Ltd. added a piece of information on the freezing of shares. The executor is Greenland Holding Group Co., Ltd., and the amount of frozen shares is about 2.53 billion RMB. The freezing period is from December 9, 2024 to December 8, 2027. The enforcement court is Wanzhou District People's Court in Chongqing.Leshan Guotou Group and others set up an industrial guidance equity investment fund with a capital contribution of 4.5 billion yuan. According to Tianyancha App, recently, Leshan Jiarong Industrial Guidance Equity Investment Fund Partnership (Limited Partnership) was established, and the executive partner is Leshan Guorong Equity Investment Fund Management Co., Ltd., with a capital contribution of 4.5 billion yuan, and its business scope includes investment activities with its own funds. According to the partner information, the fund is jointly funded by Leshan State-owned Assets Investment and Operation (Group) Co., Ltd., Leshan Finance Bureau and Leshan Guorong Equity Investment Fund Management Co., Ltd.President of Hilton Asia Pacific: India's outbound travel will be the story of the next decade. According to the data of the World Tourism and Travel Council, in 2023, Indian tourists spent $34.2 billion on outbound travel. Allen Watts, president of Hilton Asia Pacific, said that compared with the future, the current level of Indian outbound travel consumption is "negligible". "The story of India is unfolding before us," he said. "India's outbound travel will be the story of the next decade." According to the World Tourism and Travel Council's Economic Impact in 2024 report, by 2034, the outbound spending of Indian tourists is expected to more than double, reaching 76.8 billion US dollars, which will make India's position in the global tourism consumption country rise from the 12th in 2023 to the 7th.

The OpenAI webpage shows that API, ChatGPT and Sora are all running normally.Leshan Guotou Group and others set up an industrial guidance equity investment fund with a capital contribution of 4.5 billion yuan. According to Tianyancha App, recently, Leshan Jiarong Industrial Guidance Equity Investment Fund Partnership (Limited Partnership) was established, and the executive partner is Leshan Guorong Equity Investment Fund Management Co., Ltd., with a capital contribution of 4.5 billion yuan, and its business scope includes investment activities with its own funds. According to the partner information, the fund is jointly funded by Leshan State-owned Assets Investment and Operation (Group) Co., Ltd., Leshan Finance Bureau and Leshan Guorong Equity Investment Fund Management Co., Ltd.The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)